Life Science Analytics Market

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, Clinical trial, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery, End User, Region - Global Forecast to 2025

Report Code: HIT 4869 Sep, 2020, by marketsandmarkets.com

[301 Pages Report] The global life science analytics market size is projected to reach USD 42.0 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 13.7% during the forecast period. Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales and marketing applications, the need for improved data standardization, increasing prevalence of chronic diseases, growing pressure to curb healthcare spending, and the need for improved patient outcomes. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent. 

Attractive Opportunities In The Life Science Analytics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Covid-19 Impact on the Life Science Analytics Market

The current COVID-19 pandemic has resulted in a massive number of patients visiting healthcare facilities daily. According to WHO data, there were 21.5 million confirmed COVID-19 cases and 766,663 deaths globally, as of August 16, 2020. Owing to this, there is a major shortage of hospital beds, healthcare providers, and basic medical equipment. Due to the COVID-19 outbreak, the number of teleconsultations has increased. The integration of EHR with other healthcare IT solutions such as telemedicine and e-prescribing functionalities aid healthcare providers in creating an interconnected network that ensures the use of HCIT to diagnose and prescribe medicines for patients. Thus, the growing number of COVID-19 cases, the shortage of healthcare providers, and the need for better patient data management are expected to increase the demand for Life Science Analytics is expected in the coming five years. 

Life Science Analytics Market Dynamics

Driver: Technological advancements

Over the last few years, pharmaceutical companies are increasingly considering digitization as a strategic initiative that can potentially help transform different components of their value chain to become more productive and profitable. With the help of digital technologies, such as mobility and pervasive computing, big data, and analytics, companies can effectively improve their R&D productivity, manufacturing capabilities, sales and marketing effectiveness, and compliance management. In manufacturing processes, analytics technologies are being integrated to capture unit operations data automatically, and in R&D, numerous labs are going paperless. This approach has helped reduce process times and minimize errors. 

Restraints:  High implementation costs

High costs make these solutions less affordable for small- and medium-sized pharma and biotech companies and CROs with limited budgets, thereby limiting their adoption. This trend is particularly evident in emerging economies, where it is always a struggle to secure budgets for IT over medical equipment. 

Opportunities: Use of analytics in precision and personalized medicine

Precision medicine involves the use of genomic data of an individual to develop personalized medicine. Advanced analytics and predictive modeling applications can enable organizations to treat each patient in a personalized way to produce the best possible outcomes. Over the years, analytics has increasingly been used to develop personalized medicine, primarily for cancer and diabetes. To develop analytics-based solutions for precision health, various organizations are receiving grants to develop personalized medicine based on big data solutions. 

Challenges: Data privacy issues

The rising number of databases shared among research institutions, CROs, partners, and software companies have increased the risk of exposing sensitive patient information to undesired individuals. The Health Information Technology for Economic and Clinical Health Act (HITECH Act) in the US states that covered entities must protect individual health records and other identifiable health information by acquiring appropriate safeguards to protect privacy. The application of electronic tools for patient databases increases concerns regarding the safety and privacy of data. This creates a key challenge for pharmaceutical enterprises to comply with privacy policies while using analytics solutions. 

The descriptive analytics segment accounted for the largest share of the life science analytics market, by type, in 2019

Based on type, the life science analytics market is segmented into descriptive, predictive, and prescriptive analytics. The descriptive analytics segment accounted for the largest market share in 2019. This can be attributed to the significant usage of descriptive analytics by life science stakeholders to gain a better understanding of the past trends and events occurring in real-time. 

The sales & marketing segment is projected to grow at the highest CAGR during the forecast period

Based on application, the life science analytics market is segmented into research & development (clinical trials and preclinical trials), sales & marketing, regulatory compliance, supply chain optimization, and pharmacovigilance. The sales & marketing segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of analytics by life science companies to align their sales & marketing campaigns. The growing importance of post-marketing surveillance is also boosting the utilization of analytics for sales & marketing. 

The pharmaceutical & biotechnology companies segment accounted for the largest share of the life science analytics market in 2019.

Based on end-users, the life science analytics market is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators (TPAs). The pharmaceutical & biotechnology companies segment commanded the largest share of the life science analytics market in 2019. This can be attributed to the high utilization of analytics solutions by pharmaceutical & biotechnology companies. 

The Asia Pacific region is expected to show the highest growth rate during the forecast period.

On the basis of region, the life science analytics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the market, followed by Europe. However, Asia is expected to grow at the highest CAGR during the forecast period owing to the increasing prevalence of chronic diseases, growth of the life science industry, rising adoption of advanced technologies, and the growing focus of major players on increasing their presence in emerging Asian countries.

Life Science Analytics Market By Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The life science analytics market is a highly diversified and competitive market, with a large number of players, including mid-tier companies and startup firms, competing for market shares. Oracle Corporation (US), Accenture (Ireland), SAS Institute Inc. (US), IBM Corporation (US), IQVIA (US), Wipro (India), Cognizant (US), SCIO Health Analytics (US), Allscripts Healthcare Solutions (US), Cerner Corporation (US), Microsoft (US), Infosys Limited (US), MaxisIT (US), Optum (US), and Cotiviti (US) are some of the key players in this market. 

Scope of the Report:

The Life Science Analytics market research report categorizes the market into the following segments and subsegments:

By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

By Component

  • Services
  • Software 

By Delivery Model

  • On-premise model
  • On-demand model 

By Application

  • Research & Development
  • Preclinical Trials
  • Clinical Trials
  • Sales & Marketing
  • Regulatory Compliance
  • Supply Chain Optimization
  • Pharmacovigilance 

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third-party Administrators 

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of World 

Recent Developments 

  • In February 2020, IQVIA had launched Avacare Clinical Research Network that is a global-based site network, which would help provide more opportunities and patient options for clinical trials.
  • In May 2019, SAS Institute (US) opened its SAS Cloud offering in an Amazon Web Services' Data Center in Singapore.
  • In July 2017, Accenture (Ireland) acquired LabAnswer (US). This acquisition strengthened Accenture's product portfolio in digital technologies.
  • In February 2019, IQVIA acquired Linguamatics that helped the company expand its product portfolio of AI and machine learning technologies.
  • In March 2017, Cognizant (US) acquired Brilliant Service Co. Ltd. (Japan) to expand its capabilities in digital strategy, product design and engineering, the Internet of Things (IoT), and enterprise mobility 

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst


Table Of Content

1 INTRODUCTION (Page No. - 48)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                 FIGURE 1 LIFE SCIENCE ANALYTICS: MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES
    1.8 LIMITATIONS OF THE CURRENT EDITION

2 RESEARCH METHODOLOGY (Page No. - 52)
    2.1 RESEARCH DATA
        FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY SOURCES
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY SOURCES
                 FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                            FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
    2.2 MARKET SIZE ESTIMATION
        FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
        FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
        FIGURE 7 BOTTOM-UP APPROACH
        FIGURE 8 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
        FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 63)
  FIGURE 10 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
  FIGURE 11 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020 VS. 2025 (USD BILLION)
  FIGURE 12 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020 VS. 2025 (USD BILLION)
  FIGURE 13 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020 VS. 2025 (USD BILLION)
  FIGURE 14 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020 VS. 2025 (USD BILLION)
  FIGURE 15 GEOGRAPHICAL SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET

4 PREMIUM INSIGHTS (Page No. - 67)
    4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW
        FIGURE 16 TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS ARE DRIVING MARKET GROWTH
    4.2 LIFE SCIENCE ANALYTICS MARKET, BY TYPE
        FIGURE 17 DESCRIPTIVE ANALYTICS TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET IN 2020
    4.3 LIFE SCIENCE ANALYTICS MARKET, BY END USER
        FIGURE 18 NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE LIFE SCIENCE ANALYTICS END-USER MARKET IN 2020
    4.4 GEOGRAPHIC SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET
        FIGURE 19 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 71)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
        FIGURE 20 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements
                    5.2.1.2 Big data in the life science industry
                    5.2.1.3 Growing adoption of analytics solutions in clinical trials
                    5.2.1.4 Increasing adoption of analytics for sales and marketing applications
                    5.2.1.5 Need for improved data standardization
                    5.2.1.6 Increasing prevalence of chronic diseases
                    5.2.1.7 Growing pressure to curb healthcare spending and the need for improved patient outcomes
                            FIGURE 21 HEALTHCARE SPENDING AS A PERCENTAGE OF THE GDP, BY COUNTRY, 2017
           5.2.2 RESTRAINTS
                    5.2.2.1 High implementation costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing focus on value-based medicine
                    5.2.3.2 Use of analytics in precision and personalized medicine
                    5.2.3.3 Use of big data analytics to increase R&D productivity
                    5.2.3.4 Emergence of social media and its impact on the life science industry
           5.2.4 CHALLENGES
                    5.2.4.1 Data privacy issues
                    5.2.4.2 Data integration in the life science ecosystem
                    5.2.4.3 Dearth of skilled personnel
    5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE LIFE SCIENCE ANALYTICS MARKET
        FIGURE 22 IMPACT OF COVID-19 ON THE LIFE SCIENCE ANALYTICS MARKET

6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE (Page No. - 81)
    6.1 INTRODUCTION
        TABLE 1 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
        TABLE 2 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    6.2 DESCRIPTIVE ANALYTICS
           6.2.1 DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET
                 TABLE 3 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 4 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 5 NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 6 NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 7 EUROPE: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 8 EUROPE: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 9 ASIA PACIFIC: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 10 ASIA PACIFIC: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    6.3 PREDICTIVE ANALYTICS
           6.3.1 PREDICTIVE ANALYTICS SOLUTIONS CAN HELP INCREASE THE ACCURACY OF DATA-A KEY FACTOR DRIVING MARKET GROWTH
                 TABLE 11 PREDICTIVE ANALYTICS MARKET, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 12 PREDICTIVE ANALYTICS MARKET, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 13 NORTH AMERICA: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 14 NORTH AMERICA: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 15 EUROPE: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 16 EUROPE: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 17 ASIA PACIFIC: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 18 ASIA PACIFIC: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    6.4 PRESCRIPTIVE ANALYTICS
           6.4.1 PRESCRIPTIVE ANALYTICS SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
                 TABLE 19 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 20 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 21 NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 22 NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 23 EUROPE: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 24 EUROPE: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 25 ASIA PACIFIC: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 26 ASIA PACIFIC: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)

7 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION (Page No. - 93)
    7.1 INTRODUCTION
        TABLE 27 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
        TABLE 28 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
    7.2 RESEARCH & DEVELOPMENT
        TABLE 29 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2019 (USD MILLION)
        TABLE 30 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2020-2025 (USD MILLION)
        TABLE 31 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2017-2019 (USD MILLION)
        TABLE 32 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2020-2025 (USD MILLION)
        TABLE 33 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2017-2019 (USD MILLION)
        TABLE 34 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020-2025 (USD MILLION)
        TABLE 35 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2017-2019 (USD MILLION)
        TABLE 36 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020-2025 (USD MILLION)
        TABLE 37 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2017-2019 (USD MILLION)
        TABLE 38 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2020-2025 (USD MILLION)
           7.2.1 CLINICAL TRIALS
                    7.2.1.1 Need to streamline clinical trials and reduce the time and cost of drug development to drive the demand for analytics solutions
                            TABLE 39 CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2017-2019 (USD MILLION)
                            TABLE 40 CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2020-2025 (USD MILLION)
                            TABLE 41 NORTH AMERICA: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                            TABLE 42 NORTH AMERICA: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                            TABLE 43 EUROPE: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                            TABLE 44 EUROPE: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                            TABLE 45 ASIA PACIFIC: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                            TABLE 46 ASIA PACIFIC: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
           7.2.2 PRECLINICAL TRIALS
                    7.2.2.1 Analytics solutions for preclinical trials help in the entire discovery and research value chain
                            TABLE 47 PRECLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2017-2019 (USD MILLION)
                            TABLE 48 PRECLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2020-2025 (USD MILLION)
                            TABLE 49 NORTH AMERICA: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                            TABLE 50 NORTH AMERICA: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                            TABLE 51 EUROPE: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                            TABLE 52 EUROPE: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                            TABLE 53 ASIA PACIFIC: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                            TABLE 54 ASIA PACIFIC: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    7.3 SALES & MARKETING
           7.3.1 SALES & MARKETING ANALYTICS ARE ESSENTIAL TO INCREASE REVENUE AND PROFITABILITY
                 TABLE 55 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 56 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 57 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 58 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 59 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 60 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 61 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 62 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2020-2025 (USD MILLION)
    7.4 PHARMACOVIGILANCE
           7.4.1 PLAYERS OPERATING IN THIS SEGMENT ARE INCREASINGLY FOCUSING ON NEW PRODUCT LAUNCHES
                 TABLE 63 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 64 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 65 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 66 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 67 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 68 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 69 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 70 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2020-2025 (USD MILLION)
    7.5 REGULATORY COMPLIANCE
           7.5.1 STRINGENT REQUIREMENTS HAVE SUPPORTED THE NEED FOR COMPLIANCE ADHERENCE SOLUTIONS
                 TABLE 71 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 72 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 73 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 74 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 75 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 76 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 77 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 78 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2020-2025 (USD MILLION)
    7.6 SUPPLY CHAIN OPTIMIZATION
           7.6.1 GROWING NEED TO REDUCE LOGISTICS COSTS TO DRIVE THE ADOPTION OF ANALYTICS SOLUTIONS
                 TABLE 79 LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 80 LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 81 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 82 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 83 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 84 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 85 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 86 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2020-2025 (USD MILLION)

8 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT (Page No. - 118)
    8.1 INTRODUCTION
        TABLE 87 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
        TABLE 88 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
    8.2 SERVICES
           8.2.1 SERVICES FORM A LARGER COMPONENT OF THE LIFE SCIENCE ANALYTICS MARKET
                 TABLE 89 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 90 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 91 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 92 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 93 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 94 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 95 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 96 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    8.3 SOFTWARE
           8.3.1 LIFE SCIENCE ANALYTICS SOFTWARE SOLUTIONS ENABLE PHARMA-BIOTECH COMPANIES TO MANAGE CLINICAL TRIALS DATA
                 TABLE 97 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 98 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 99 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 100 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 101 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 102 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 103 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 104 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2020-2025 (USD MILLION)

9 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL (Page No. - 127)
    9.1 INTRODUCTION
        TABLE 105 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
        TABLE 106 LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
    9.2 ON-PREMISE DELIVERY MODEL
           9.2.1 ON-PREMISE SOLUTIONS OFFER MULTIVENDOR ARCHITECTURE, WHICH LOWERS THE RISK OF DATA BREACHES & EXTERNAL ATTACKS
                 TABLE 107 ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 108 ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 109 NORTH AMERICA: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 110 NORTH AMERICA: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 111 EUROPE: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 112 EUROPE: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 113 ASIA PACIFIC: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 114 ASIA PACIFIC: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    9.3 ON-DEMAND DELIVERY MODEL
           9.3.1 INCREASING VOLUME OF DATA GENERATED ACROSS THE LIFE SCIENCE INDUSTRY WILL DRIVE THE ADOPTION OF ON-DEMAND SOLUTIONS
                 TABLE 115 ON-DEMAND SOLUTIONS OFFERED IN THE MARKET
                 TABLE 116 ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2017-2019 (USD MILLION)
                 TABLE 117 ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2020-2025 (USD MILLION)
                 TABLE 118 NORTH AMERICA: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 119 NORTH AMERICA: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 120 EUROPE: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 121 EUROPE: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
                 TABLE 122 ASIA PACIFIC: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
                 TABLE 123 ASIA PACIFIC: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)

10 LIFE SCIENCE ANALYTICS MARKET, BY END USER (Page No. - 136)
     10.1 INTRODUCTION
          TABLE 124 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
          TABLE 125 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
     10.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
            10.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
                   TABLE 126 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2019 (USD MILLION)
                   TABLE 127 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2025 (USD MILLION)
                   TABLE 128 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 129 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 130 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 131 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 132 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 133 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2025 (USD MILLION)
     10.3 MEDICAL DEVICE COMPANIES
            10.3.1 ADOPTION OF BIG DATA ANALYTICS IS HELPING MEDICAL DEVICE MANUFACTURERS SECURE A COMPETITIVE ADVANTAGE IN THE INDUSTRY
                   TABLE 134 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2017-2019 (USD MILLION)
                   TABLE 135 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2020-2025 (USD MILLION)
                   TABLE 136 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 137 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 138 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 139 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 140 ASIA PACIFIC -PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 141 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020-2025 (USD MILLION)
     10.4 RESEARCH CENTERS
            10.4.1 INCREASING RESEARCH ACTIVITIES TO DRIVE THE ADOPTION OF ANALYTICS SOLUTIONS IN THIS END-USER SEGMENT
                   TABLE 142 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2017-2019 (USD MILLION)
                   TABLE 143 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2020-2025 (USD MILLION)
                   TABLE 144 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 145 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 146 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 147 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 148 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 149 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020-2025 (USD MILLION)
     10.5 THIRD-PARTY ADMINISTRATORS
            10.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
                   TABLE 150 LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2017-2019 (USD MILLION)
                   TABLE 151 LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2020-2025 (USD MILLION)
                   TABLE 152 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 153 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 154 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 155 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020-2025 (USD MILLION)
                   TABLE 156 ASIA PACIFIC -PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2017-2019 (USD MILLION)
                   TABLE 157 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2020-2025 (USD MILLION)

11 LIFE SCIENCE ANALYTICS MARKET, BY REGION (Page No. - 151)
     11.1 INTRODUCTION
          TABLE 158 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2017-2019 (USD MILLION)
          TABLE 159 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2020-2025 (USD MILLION)
     11.2 NORTH AMERICA
          FIGURE 23 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
          TABLE 160 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
          TABLE 161 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
          TABLE 162 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 163 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 164 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
          TABLE 165 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
          TABLE 166 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 167 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 168 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
          TABLE 169 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
          TABLE 170 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
          TABLE 171 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
          TABLE 172 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
          TABLE 173 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.2.1 US
                     11.2.1.1 Strong economy and increasing R&D expenditure are expected to drive the growth of the life science analytics market in the US
                              TABLE 174 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 175 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 176 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 177 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                              TABLE 178 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 179 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 180 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 181 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 182 US: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 183 US: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 184 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 185 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.2.2 CANADA
                     11.2.2.1 Rising need for data standardization in the life science industry to support market growth in Canada
                              TABLE 186 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 187 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 188 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 189 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION,2020-2025 (USD MILLION)
                              TABLE 190 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 191 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 192 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 193 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 194 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 195 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 196 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 197 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
     11.3 EUROPE
          TABLE 198 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
          TABLE 199 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
          TABLE 200 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 201 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 202 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
          TABLE 203 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
          TABLE 204 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 205 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 206 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
          TABLE 207 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
          TABLE 208 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
          TABLE 209 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
          TABLE 210 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
          TABLE 211 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.3.1 GERMANY
                     11.3.1.1 Growing R&D investments by pharmaceutical and biotechnology companies to drive market growth in Germany
                              TABLE 212 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 213 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 214 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 215 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                              TABLE 216 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 217 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 218 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 219 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 220 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 221 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 222 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 223 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.3.2 FRANCE
                     11.3.2.1 Growing government support for the adoption of AI and big data analytics to drive market growth in France
                              TABLE 224 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 225 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 226 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 227 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                              TABLE 228 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 229 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 230 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 231 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 232 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 233 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 234 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 235 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.3.3 UK
                     11.3.3.1 UK to dominate the European life science analytics market during the forecast period
                              TABLE 236 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 237 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 238 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 239 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                              TABLE 240 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 241 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 242 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 243 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 244 UK: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 245 UK: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 246 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 247 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.3.4 REST OF EUROPE
                   TABLE 248 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                   TABLE 249 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                   TABLE 250 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                   TABLE 251 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                   TABLE 252 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                   TABLE 253 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                   TABLE 254 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                   TABLE 255 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                   TABLE 256 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                   TABLE 257 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                   TABLE 258 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                   TABLE 259 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
     11.4 ASIA PACIFIC
          FIGURE 24 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
          TABLE 260 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
          TABLE 261 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
          TABLE 262 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 263 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 264 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
          TABLE 265 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
          TABLE 266 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 267 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 268 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
          TABLE 269 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
          TABLE 270 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
          TABLE 271 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
          TABLE 272 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
          TABLE 273 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.4.1 JAPAN
                     11.4.1.1 Growing government support for clinical R&D activities to drive the demand for analytics solutions in Japan
                              TABLE 274 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 275 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 276 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 277 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                              TABLE 278 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 279 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 280 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 281 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 282 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 283 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 284 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 285 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.4.2 CHINA
                     11.4.2.1 Growth of the life science industry to drive market growth in China
                              TABLE 286 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 287 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 288 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 289 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                              TABLE 290 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 291 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 292 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 293 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 294 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 295 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 296 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 297 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.4.3 INDIA
                     11.4.3.1 Rising R&D budgets and a growing number of drug development-based research activities to support market growth in India
                              TABLE 298 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 299 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 300 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                              TABLE 301 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                              TABLE 302 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                              TABLE 303 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                              TABLE 304 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                              TABLE 305 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                              TABLE 306 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                              TABLE 307 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                              TABLE 308 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                              TABLE 309 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
            11.4.4 REST OF ASIA PACIFIC
                   TABLE 310 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
                   TABLE 311 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
                   TABLE 312 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
                   TABLE 313 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
                   TABLE 314 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
                   TABLE 315 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
                   TABLE 316 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
                   TABLE 317 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
                   TABLE 318 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
                   TABLE 319 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
                   TABLE 320 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
                   TABLE 321 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)
     11.5 REST OF THE WORLD
          TABLE 322 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 323 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 324 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
          TABLE 325 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2020-2025 (USD MILLION)
          TABLE 326 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2017-2019 (USD MILLION)
          TABLE 327 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH AND DEVELOPMENT APPLICATIONS, BY TYPE, 2020-2025 (USD MILLION)
          TABLE 328 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2019 (USD MILLION)
          TABLE 329 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2020-2025 (USD MILLION)
          TABLE 330 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2019 (USD MILLION)
          TABLE 331 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2020-2025 (USD MILLION)
          TABLE 332 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2019 (USD MILLION)
          TABLE 333 REST OF WORLD: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2020-2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 217)
     12.1 OVERVIEW
          FIGURE 25 KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN THE LIFE SCIENCE ANALYTICS MARKET FROM 2016 TO AUGUST 2020
     12.2 MARKET EVALUATION FRAMEWORK
          FIGURE 26 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES
     12.3 MARKET PLAYER RANKING
          FIGURE 27 LIFE SCIENCE ANALYTICS MARKET PLAYER RANKING, 2018
     12.4 COMPETITIVE SITUATION AND TRENDS
             12.4.1 PRODUCT LAUNCHES
                    TABLE 334 PRODUCT LAUNCHES
             12.4.2 EXPANSIONS
                    TABLE 335 EXPANSIONS
             12.4.3 ACQUISITIONS
                    TABLE 336 ACQUISITIONS
             12.4.4 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
                    TABLE 337 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS

13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 223)
     13.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
     13.2 COMPANY EVALUATION MATRIX
             13.2.1 STARS
             13.2.2 EMERGING LEADERS
             13.2.3 PERVASIVE PLAYERS
             13.2.4 PARTICIPANTS
                    FIGURE 28 COMPETITIVE LEADERSHIP MAPPING OF THE LIFE SCIENCE ANALYTICS MARKET: OVERALL MARKET
     13.3 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES
             13.3.1 PROGRESSIVE COMPANIES
             13.3.2 STARTING BLOCKS
             13.3.3 RESPONSIVE COMPANIES
             13.3.4 DYNAMIC COMPANIES
                    FIGURE 29 COMPETITIVE LEADERSHIP MAPPING OF THE LIFE SCIENCE ANALYTICS MARKET: START-UPS/SMES
     13.4 COMPANY PROFILES
             13.4.1 OVERVIEW
     13.5 IBM CORPORATION
             13.5.1 BUSINESS OVERVIEW
                    FIGURE 30 IBM CORPORATION: COMPANY SNAPSHOT (2019
             13.5.2 PRODUCTS & SERVICES OFFERED
             13.5.3 RECENT DEVELOPMENTS
             13.5.4 MNM VIEW
                      13.5.4.1 Key strengths/right to win
                      13.5.4.2 Strategic choices made
                      13.5.4.3 Weaknesses and competitive threats
     13.6 ORACLE CORPORATION
             13.6.1 BUSINESS OVERVIEW
                    FIGURE 31 ORACLE CORPORATION: COMPANY SNAPSHOT (2019
             13.6.2 PRODUCTS & SERVICES OFFERED
             13.6.3 RECENT DEVELOPMENTS
             13.6.4 MNM VIEW
                      13.6.4.1 Key strengths/right to win
                      13.6.4.2 Strategic choices made
                      13.6.4.3 Weaknesses and competitive threats
     13.7 SAS INSTITUTE INC.
             13.7.1 BUSINESS OVERVIEW
                    FIGURE 32 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2019
             13.7.2 PRODUCTS & SERVICES OFFERED
             13.7.3 RECENT DEVELOPMENTS
             13.7.4 MNM VIEW
                      13.7.4.1 Key strengths/right to win
                      13.7.4.2 Strategic choices made
                      13.7.4.3 Weaknesses and competitive threats
     13.8 ACCENTURE
             13.8.1 BUSINESS OVERVIEW
                    FIGURE 33 ACCENTURE: COMPANY SNAPSHOT (2019
             13.8.2 PRODUCTS OFFERED
             13.8.3 RECENT DEVELOPMENTS
             13.8.4 MNM VIEW
                      13.8.4.1 Key strengths/right to win
                      13.8.4.2 Strategic choices made
                      13.8.4.3 Weaknesses and competitive threats
     13.9 IQVIA
             13.9.1 BUSINESS OVERVIEW
                    FIGURE 34 IQVIA: COMPANY SNAPSHOT (2019
             13.9.2 PRODUCTS OFFERED
             13.9.3 RECENT DEVELOPMENTS
             13.9.4 MNM VIEW
                      13.9.4.1 Key strengths/right to win
                      13.9.4.2 Strategic choices made
                      13.9.4.3 Weaknesses and competitive threats
     13.1 COGNIZANT
             13.10.1 BUSINESS OVERVIEW
                     FIGURE 35 COGNIZANT: COMPANY SNAPSHOT (2019
             13.10.2 PRODUCTS & SERVICES OFFERED
             13.10.3 RECENT DEVELOPMENTS
     13.11 WIPRO LIMITED
             13.11.1 BUSINESS OVERVIEW
                     FIGURE 36 WIPRO LIMITED: COMPANY SNAPSHOT (2019
             13.11.2 PRODUCTS & SERVICES OFFERED
             13.11.3 RECENT DEVELOPMENTS
     13.12 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
             13.12.1 BUSINESS OVERVIEW
                     FIGURE 37 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2019
             13.12.2 PRODUCTS & SERVICES OFFERED
             13.12.3 RECENT DEVELOPMENTS
     13.13 OPTUM
             13.13.1 BUSINESS OVERVIEW
                     FIGURE 38 OPTUM: COMPANY SNAPSHOT (2019
             13.13.2 PRODUCTS OFFERED
             13.13.3 RECENT DEVELOPMENTS
     13.14 MICROSOFT CORPORATION
             13.14.1 BUSINESS OVERVIEW
                     FIGURE 39 MICROSOFT: COMPANY SNAPSHOT (2019
             13.14.2 PRODUCTS OFFERED
             13.14.3 RECENT DEVELOPMENTS
     13.15 MAXISIT
             13.15.1 BUSINESS OVERVIEW
             13.15.2 PRODUCTS & SERVICES OFFERED
     13.16 SCIO HEALTH ANALYTICS
             13.16.1 BUSINESS OVERVIEW
             13.16.2 PRODUCTS & SERVICES OFFERED
             13.16.3 RECENT DEVELOPMENTS
     13.17 TAKE SOLUTIONS
             13.17.1 BUSINESS OVERVIEW
                     FIGURE 40 TAKE SOLUTIONS: COMPANY SNAPSHOT (2019
             13.17.2 PRODUCTS & SERVICES OFFERED
     13.18 CERNER CORPORATION
             13.18.1 BUSINESS OVERVIEW
                     FIGURE 41 CERNER CORPORATION: COMPANY SNAPSHOT (2019
             13.18.2 PRODUCTS OFFERED
             13.18.3 RECENT DEVELOPMENTS
     13.19 COTIVITI HOLDINGS, INC.
             13.19.1 BUSINESS OVERVIEW
             13.19.2 SERVICES OFFERED
     13.2 OTHER COMPANIES
             13.20.1 THOUGHTSPOT
             13.20.2 PYRAMID ANALYTICS
             13.20.3 ALTERYX
             13.20.4 SISENSE
             13.20.5 AMAZON WEB SERVICES

14 ADJACENT & RELATED MARKETS (Page No. - 267)
     14.1 INTRODUCTION
             14.1.1 LIMITATION
     14.2 AI IN DRUG DISCOVERY MARKET
             14.2.1 MARKET DEFINITION
             14.2.2 MARKET OVERVIEW
                    TABLE 338 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING, 2017-2024 (USD MILLION)
                    TABLE 339 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 340 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 341 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
                    TABLE 342 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2017-2024 (USD MILLION)
                    TABLE 343 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 344 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 345 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 346 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR REINFORCEMENT LEARNING, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 347 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR UNSUPERVISED LEARNING, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 348 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER MACHINE LEARNING TECHNOLOGIES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 349 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017-2024 (USD MILLION)
                    TABLE 350 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
                    TABLE 351 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR IMMUNO-ONCOLOGY, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 352 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 353 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 354 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR METABOLIC DISEASES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 355 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 356 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY END USER, 2017-2024 (USD MILLION)
                    TABLE 357 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 358 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 359 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 360 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY REGION, 2017-2024 (USD MILLION)
                    14.3 DRUG DISCOVERY INFORMATICS MARKET
             14.3.1 MARKET DEFINITION
             14.3.2 INCLUSIONS & EXCLUSIONS
             14.3.3 MARKET OVERVIEW
                    TABLE 361 DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017-2025 (USD MILLION)
                    TABLE 362 DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 363 DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 364 DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELING, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 365 DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARY & DATABASE PREPARATION, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 366 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 367 DRUG DISCOVERY INFORMATICS MARKET, BY APPLICATION, 2017-2025 (USD MILLION)
                    TABLE 368 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DEVELOPMENT APPLICATIONS, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 369 DRUG DISCOVERY INFORMATICS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 370 DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION,  2017-2025 (USD MILLION)
                    TABLE 371 DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 372 DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 373 DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017-2025 (USD MILLION)
                    TABLE 374 DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 375 DRUG DISCOVERY INFORMATICS MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 376 DRUG DISCOVERY INFORMATICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 377 DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2017-2025 (USD MILLION)
                    TABLE 378 DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2017-2025 (USD MILLION)
     14.4 HEALTHCARE ANALYTICS MARKET
             14.4.1 MARKET DEFINITION
             14.4.2 MARKET OVERVIEW
                    TABLE 379 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
                    TABLE 380 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 381 PREDICTIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 382 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 383 COGNITIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 384 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
                    TABLE 385 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
                    TABLE 386 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 387 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 388 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 389 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION, 2019-2024 (USD MILLION)
                    TABLE 390 HEALTHCARE ANALYTICS HARDWARE MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 391 HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL,  2017-2024 (USD MILLION)
                    TABLE 392 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE DELIVERY MODELS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 393 HEALTHCARE ANALYTICS MARKET FOR ON-DEMAND DELIVERY MODELS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 394 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
                    TABLE 395 FINANCIAL ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
                    TABLE 396 FINANCIAL ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 397 CLAIMS PROCESSING MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 398 REVENUE CYCLE MANAGEMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 399 PAYMENT INTEGRITY & FWA MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 400 RISK ADJUSTMENT & ASSESSMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 401 CLINICAL ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
                    TABLE 402 CLINICAL ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 403 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 404 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 405 REPORTING & COMPLIANCE MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 406 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 407 PRECISION HEALTH MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 408 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 409 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
                    TABLE 410 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 411 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 412 WORKFORCE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 413 STRATEGIC ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 414 POPULATION HEALTH ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 415 HEALTHCARE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
                    TABLE 416 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2017-2024 (USD MILLION)
                    TABLE 417 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 418 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 419 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 420 HEALTHCARE ANALYTICS MARKET FOR EMPLOYERS AND PRIVATE EXCHANGES, BY REGION, 2019-2024 (USD MILLION)
                    TABLE 421 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE,2017-2024 (USD MILLION)
                    TABLE 422 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS, PHYSICIAN PRACTICES, AND IDNS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 423 HEALTHCARE ANALYTICS MARKET FOR PACOS, BY REGION,2017-2024 (USD MILLION)
                    TABLE 424 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SETTINGS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 425 HEALTHCARE ANALYTICS MARKET FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2017-2024 (USD MILLION)
                    TABLE 426 HEALTHCARE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)

15 APPENDIX (Page No. - 295)
     15.1 DISCUSSION GUIDE
     15.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
     15.3 AVAILABLE CUSTOMIZATIONS
     15.4 RELATED REPORTS
     15.5 AUTHOR DETAILS

The study involved four major activities in estimating the current size of the global life science analytics market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was mainly used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the life science analytics market. Secondary sources include directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers; and annual reports were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of primary respondents:

Breakdown of Primary Interviews 

Life Science Analytics Market Size

To know about the assumptions considered for the study, download the pdf brochure

Note: Others include sales managers, marketing managers, and product managers. 

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the life science analytics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The revenue generated from the sale of life science analytics solutions and services by leading players has been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources 

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides. 

Objectives of the Study

  • To define, describe, and forecast the life science analytics market based on type, component, application, delivery mode, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to the individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as partnerships, agreements, mergers & acquisitions, expansions, product & service launches/upgrades, and R&D activities in the life science analytics market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the rest of world life science analytics market including Latin America and Middle East and Africa

Company Information

  • Detailed analysis and profiling of additional market players
COVID-19

Get in-depth analysis of the COVID-19 impact on the Life Science Analytics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Life Science Analytics Market

Request For Special Pricing
Report Code
HIT 4869
Published ON
Sep, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Life Science Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home